Composition
- Active ingredients
- BUPRENORPHINE HYDROCHLORIDE EQ 16MG BASE; NALOXONE HYDROCHLORIDE EQ 4MG BASE
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA208042.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cassipa
- Active substance
- buprenorphine hydrochloride
- Route
- Under the tongue
- Dosage form
- Film
- Applicant
- Teva Pharms USA
- Status
- Discontinued
- FDA approval
- 7 Sept 2018
- Application
- NDA208042-001